SCOPUS 정보 검색 플랫폼

International Journal of Antimicrobial Agents

Volumn 34, Issue 3, 2009, Pages 282-283

Extended daily dialysis does not affect the pharmacokinetics of anidulafungin

(4) Burkhardt, Olaf a,b Kaever, Volkhard a Burhenne, Heike a Kielstein, Jan T a

a HANNOVER MEDICAL SCHOOL (Germany)

b Central Clinic Bad Berka (Germany)

Author keywords

Acute kidney injury; Anidulafungin; Extended daily dialysis; Pharmacokinetics

Indexed keywords

ANIDULAFUNGIN;

ACUTE KIDNEY FAILURE; ADULT; AREA UNDER THE CURVE; CANDIDA ALBICANS; CANDIDIASIS; CASE REPORT; CHOLECYSTITIS; DISTRIBUTION VOLUME; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; EXTENDED DAILY DIALYSIS; HUMAN; LETTER; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MAXIMUM PLASMA CONCENTRATION; PRIORITY JOURNAL; SEPTIC SHOCK; SINGLE DRUG DOSE;

ANTIBIOTICS, ANTIFUNGAL; ECHINOCANDINS; HUMANS; KIDNEY DISEASES; MYCOSES; RENAL DIALYSIS; TIME FACTORS;

EID: 67650762838 PISSN: 09248579 EISSN: None Source Type: Journal
DOI: 10.1016/j.ijantimicag.2009.03.003 Document Type: Letter

Times cited : (22)

References (6)

1
- 33745700391
- Anidulafungin: a novel echinocandin
- Vazquez J.A., and Sobel J.D. Anidulafungin: a novel echinocandin. Clin Infect Dis 43 (2006) 215-222
- (2006) Clin Infect Dis , vol.43 , pp. 215-222
- Vazquez, J.A.¹ Sobel, J.D.²

2
- 33947500054
- Anidulafungin does not require dosage adjustment in subjects with varying degrees of hepatic or renal impairment
- Dowell J.A., Stogniew M., Krause D., and Damle B. Anidulafungin does not require dosage adjustment in subjects with varying degrees of hepatic or renal impairment. J Clin Pharmacol 47 (2007) 461-470
- (2007) J Clin Pharmacol , vol.47 , pp. 461-470
- Dowell, J.A.¹ Stogniew, M.² Krause, D.³ Damle, B.⁴

3
- 33644819144
- Technology insight: treatment of renal failure in the intensive care unit with extended dialysis
- Fliser D., and Kielstein J.T. Technology insight: treatment of renal failure in the intensive care unit with extended dialysis. Nat Clin Pract Nephrol 2 (2006) 32-39
- (2006) Nat Clin Pract Nephrol , vol.2 , pp. 32-39
- Fliser, D.¹ Kielstein, J.T.²

4
- 58049192974
- Pharmacokinetics of ertapenem in critically ill patients with acute renal failure undergoing extended daily dialysis
- Burkhardt O., Hafer C., Langhoff A., Kaever V., Kumar V., Welte T., et al. Pharmacokinetics of ertapenem in critically ill patients with acute renal failure undergoing extended daily dialysis. Nephrol Dial Transplant 24 (2009) 267-271
- (2009) Nephrol Dial Transplant , vol.24 , pp. 267-271
- Burkhardt, O.¹ Hafer, C.² Langhoff, A.³ Kaever, V.⁴ Kumar, V.⁵ Welte, T.⁶

5
- 37549026164
- Elimination of daptomycin in a patient with acute renal failure undergoing extended daily dialysis
- Burkhardt O., Joukhadar C., Traunmüller F., Hadem J., Welte T., and Kielstein J.T. Elimination of daptomycin in a patient with acute renal failure undergoing extended daily dialysis. J Antimicrob Chemother 61 (2008) 224-225
- (2008) J Antimicrob Chemother , vol.61 , pp. 224-225
- Burkhardt, O.¹ Joukhadar, C.² Traunmüller, F.³ Hadem, J.⁴ Welte, T.⁵ Kielstein, J.T.⁶

6
- 34548567819
- Pharmacokinetics of moxifloxacin and levofloxacin in intensive care unit patients who have acute renal failure and undergo extended daily dialysis
- Czock D., Hüsig-Linde C., Langhoff A., Schöpke T., Hafer C., de Groot K., et al. Pharmacokinetics of moxifloxacin and levofloxacin in intensive care unit patients who have acute renal failure and undergo extended daily dialysis. Clin J Am Soc Nephrol 1 (2006) 1263-1268
- (2006) Clin J Am Soc Nephrol , vol.1 , pp. 1263-1268
- Czock, D.¹ Hüsig-Linde, C.² Langhoff, A.³ Schöpke, T.⁴ Hafer, C.⁵ de Groot, K.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.